Repeated immunizations of rabbits with chemically synthesized peptides from selected regions of HLA-DP histocompatibility antigens resulted in the production of specific antibodies that were then isolated from the immune sera by chromatography on Sepharose-peptide immunoadsorbents.
Introduction
Immunization of rabbits with synthetic peptides from suitable regions of a protein one wishes to study has been used effectively as a m ethod of producing and examining antibodies specifically interreactive with that protein.
Thereby, antibodies directed against selected re gions of particular proteins have served to determine the precise structural mapping of antigenic sites and surface domains of complex molecules [1] [2] [3] .
Recently, a group of synthetic peptides, corre sponding to amino acid stretches of D R and DQ histocompatibility antigens, have been used for the generation of protein-reactive antibodies, and for localizing exposed regions in those m embrane gly coprotein [4, 5] . Thus, the sequences 61 to 73 of DR beta chain, and 63 to 96 of DO beta chain, appear to be located on the surface of the protein molecule. Those regions are highly polymorphic in DR and DO alloantigens: this confirms previous observations [4] that regions with high structural variability are likely to be exposed on the surface of membrane glycopro teins.
Polymorphism might be therefore a criterium for predicting and selecting surface domains in HLA alloantigens; unfortunately, the H LA-DP molecules do not offer many possibilities for this type of selec tion, since the amino acid sequences of the DP allo antigens known till today are surprisingly constant: apart from rare single amino acid substitutions occur ring along the chains, there is only a small 4-residue fragment (pos. 84-87) that differs between HLA-D P2 and H LA -D P3. This region might correspond to a cellular recognition site, and has a good proba bility to be expressed on the surface of the protein [6] , In this investigation, we attem pted to produce rabbit antibodies against synthetic peptides corre sponding to selected amino acid stretches of DP his tocompatibility antigens, and tested their ability to react with human glycoproteins; the binding of the antipeptides antibodies to those antigens was inter preted as evidence for the localization of the corre sponding sequence on the exterior of the molecule.
The selection of the peptides to be synthesized was based on comparison of the amino acid sequences of DP, DQ and D R glycoproteins [7] [8] [9] [10] [11] [12] [13] : in order to avoid cross-reactivities, we choose for investigation amino acid stretches in DP antigens that presented low sequence homology with either DQ molecules, or D R , or both. One of the stretches selected for synthesis (R: ß chain 80-90) included the four re sidue fragment 84-87. known to be polymorphic in DP alloantigens [6] .
The others three fragments were S (ß chain, 6 3 -7 7 ), F (ß chain, 9 4 -1 0 8 ) and D (a chain, 5 1 -6 1 ).
Materials and Methods

Peptides
The four peptides to be used for eliciting antipep tide antibodies were selected one from the alpha chain, three from the beta chain of DP histocom pati bility antigens [8, 10] .
Peptides S (D P ß chain, 63-77), F (D P ß chain, 94-108), R (D P ß chain 80-90) were synthesized by the use of a fully authom atic Beckman peptide Synthesizer, model 990B. Peptide D (DP a chain, 51-61) by m anual synthesis. The amino acid com position of all peptides was controlled by amino acid analysis after acid hydrolysis. Four additional pep tides were used for evaluating the degree of cross reactivity of the antipeptide antisera; those were P (D Q 2, 3 ß chain, 8 0 -9 0 ), Q (D Q 1 ß chain 8 0 -9 0 ), G (D O 1, 2, 3 ß chain, 94-108) and E (D O 1 a chain, 49-58). All those peptides, available from previous investigations [5] , were related in amino acid se quence to the D P peptides used for immunization. The sequence, localization, and the degree of homol ogy of all those fragments is reported in Table I . 
M onoclonal antibodies
The m onomorphic anti-Class II monoclonal anti bodies 13 A /B 6 , 11 A /B 5 and PTF 29-12 were kindly provided by Drs. Roberto Tosi and Giorgio Corte.
Production o f antisera
Three peptides (R, F, D) were used for immuniza tion: those fragments were first coupled to a carrier protein (KLH or ovalbumin) by the aid of MBS or glutaraldehvde [14] , Three NZW rabbits received an initial subcutaneous injection of 200 i_ig of peptide-KLH complex in incomplete F reud's adjuvant, and subsequently, bimonthly subcutaneous injection of 100 ng in incomplete adjuvant. The animals were first bled after three injection and then every 14 days. The blood was centrifuged for 15 min at 1600x g after standing at room tem perature for 4 h. The supernatant was stored at -20 °C until used.
Preparation o f the im m unoadsorbent and purification o f the rabbit antibodies
The peptides were bound to Sepharose-AH resin through their C-terminal cysteine by the aid of MBS, or through their N-terminal amino groups, by the aid of glutaraldehyde.
Details were similar to those described for other Sepharose-peptide immunoadsorbents [14] , The resin was washed and equilibrated with PBS, then packed in 1 x 6 cm columns.
Antibodies precipitated from the immune sera by ammonium sulfate at 32% saturation were then loaded onto the immunoadsorbent. Chrom atography was performed in PBS; adsorbed IgG were eluted with 0.2 m glycine-HCl buffer pH 2.6, immediately neutralized, dialyzed in the cold against PBS, and stored at -20 °C until used.
Enzym e-linked im m unosorbant assay
For this assay, wells of m icrotiter plates were p re coated with 1 |ig of antigen peptide, or with 2 jag of glycoproteins solubilized by nonionic detergents from the cell lines specified later. The antibody was used in serial dilutions. The antigen-antibody com plexes were reacted with peroxidase-labelled goat antirabbit IgG, and detected by addition of/?-phenylendiamine and hydrogen peroxide. Finally the plates were read in a GDV "Im m unella" at 492 nm.
M embrane glycoproteins
Human chronic lymphocytic leukemia (CLL) cells were used as a source of soluble m em brane glycopro teins. The phenotypes of the cells, as defined by RIA typing [15] , were: M embrane glycoproteins were extracted from those cells by the use of nonionic detergents, then isolated by affinity chrom atography on Lens Culinaris Lectin-Sepharose [16] .
Results
Before being used for coupling and rabbit immuni zation, peptide S (D P ß, 63 -77) was first tested in ELISA against antipeptide antibodies previously produced against three synthetic peptides of HLA-DQ and H L Q -D R glycoproteins, respectively B (D Q 1, 6 0 -7 7 ), C (D Q 2, 6 0 -7 7 ), and W (D R 2, 59 -71); those fragments corresponded approxim ate ly, in size and localization, to peptide S. Homology of S to B was 53% , that of S to C, 66% , that of S to W, 78%.
In binding assays, using peptide B and C as posi tive controls, anti-B, anti-C and anti-W antibodies cross-reacted extensively with peptide S. We con cluded therefore that the selection of peptides from this region, where H L A -D Q , -D R, -DP exhibit high sequence homology, might not be suitable for the production of specific antipeptide antibodies. Pep tide S. therefore, was not processed further.
Peptides D, F and R were linked to a carrier pro tein (KLH or ovalbumin) by the use of MBS or glutaraldehyde, and used to inject three NZW rab bits.
A fter three immunizations, the rabbits were bled from the ear, and the immune sera tested in ELISA for their affinity for the immunogen. All three sera reacted with the inciting peptide. The IgG were then precipitated with ammonium sulfate at 32% satura tion, collected by centrifugation, dissolved in water, dialyzed against PBS, and loaded on 1 x 6 cm col umns packed with the corresponding Sepharose-peptide im m unoadsorbent, equilibrated in PBS. The specific antipeptide antibodies were then eluted from the resin by 0.2 m glycine-HCl buffer pH 2.6, neu tralized with ammonium bicarbonate, dialyzed against PBS, and stored at -20 °C until used. Details of similar procedures were described elsewhere [4] , Those affinity-purified antibodies were then tested in ELISA against all synthetic peptides available, in order to evaluate cross-reactivities. Results are re ported in Fig. 1 : antibody 544 (anti-R) reacts exten sively also with peptide P (D Q 2.3, ß chain, 80-90) and to a lesser extent, with Q (D O 1 ß chain, 80-90). Sequence homology between R and P is 54% , that between R and Q, 45%. The homology of R to the same stretch in D R glycoproteins is considerably lower, so it may be predicted that this antibody will not react with HLA -D R antigens.
Antibody 211 (anti-F) cross-reacts poorly with peptide G (DO ß chain, 94-108: homology 40%). On the other hand, the homology of F to the corre sponding stretch in D R proteins is over 80%, and extensive cross-reactivity might be expected. •
------• : Ab 208 (anti-D) on peptide D, O------O: Ab 544 (anti-R) on peptide R. □ ------□: Ab 544 (anti-R) on peptide P. ■ ------■: Ab 544 (anti-R) on peptide Q, A -----A: Ab 211 (anti-F) on peptide F. A ------▲: Ab 211 (anti-F) on peptide G.
Finally, antibody 208 (anti-D) does not bind to peptide E: the homology between the two fragments is 37%. However, this antibody is expected to react with the related fragment in D R a chain, because of 73% homology.
In order to increase the selectivity of antibody 544 for peptide R and H LA -D P proteins, and to elimi nate cross-reactivity with related fragments P and Q, antibody 544 (1.5 mg in 2 ml PBS) was allowed to react for 45 min at 4 °C under gentle stirring, with a small aliquot of Sepharose-peptide P immunoadsorbent (0.2 ml packed gel). The gel was discarded by centrifugation, and the imm unodepleted antibody 544 (544 I.D .) tested again with an ELISA on the three peptides R, P, and Q. The binding data (Fig. 2) indicate a sharp drop of antibody affinity for peptides P and Q. This depleted antibody preparation, there fore, is expected to discriminate HLA-DP from H L A -D Q molecules.
The attem pt to purify antibody 208 (anti-D) by im m unodepletion, in order to avoid cross-reactivity with H L A -D R molecules, was not undertaken: previous observations [14] indicate that antipeptide antibodies elicited by related peptides with high sequence homology are completely adsorbed by 60  70  so  ?0  100  110  DP2 DEEYWNSQKDILEEERAVPDRNCRHNYELGGPITLQRRVQPRVNVSPSKKGPLQHHNLLVCH S,R,F
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Beta chains Peptides
DR 2 -A-----------QA-AV-TY-----GWES F -V ----H-Q-T-----------------S W DQ2 AA-----------RK-AV-V-----Q-ELRT------E-T-TI---RTEA-N-------S C,P
DQ 3 immunoadsorbents prepared from any of the related fragments.
AA-------E V-RT -EL-T V-----Q-ELRT------E-T -TI---RTEA-N-------S DQ 1
VA-------EV-GA-SV--V------VAYRGI-----E-T-TI---RTEA-N-------S B,Q,G
Homologies
In the last experim ent, the three antibody prepara tions 211, 208 and 544 I.D . were tested with an ELISA on mem brane glycoproteins extracted by nonionic detergents from different chronic lympho cytic leukemia (CLL) cells. As positive controls, we used three monomorphic anti-Class II mouse mono clonal antibodies, as negative controls, preimmune rabbit IgG. Rabbit antibodies were diluted to a concn. of 50 ng/ml, mouse antibodies to 8 fxg/ml. 50 |xl of those solutions were used.
In Fig. 3 , the binding of the antibodies to the anti gens is reported. A ntibody 211 (anti-F) failed to react, while antibodies 208 and 544 I.D . reacted with every soluble glycoprotein preparation. Comparison of those binding data with these obtained by using the three anti-Class II monoclonal antibodies, indi cates that the antigenic sites recognized by the two antipeptide antibodies do not correspond to these seen by the mouse antibodies. In fact, rabbit anti bodies show high affinity for glycoproteins CLL 53 and 55, mouse antibodies for CLL 54 and CLL 52. Since those latter antibodies are essentially directed against antigenic sites expressed on both DQ and DR molecules, and possibly DP, the difference in reac tivity between antipeptide antibodies and the group of monoclonal antibodies might be ascribed to the fact that antibody 544 I.D ., and possibly 208, recog nized antigenic determ inants on a restricted num ber of glycoproteins, likely DP histocompatibility anti gens.
Discussion
Three antipeptide antibodies against different regions of HLA -D P histocompatibility antigens show striking differences in their reactivities when tested against m embrane glycoproteins of cells expressing Class II antigens. In fact, antibody 211 against stretch 94-108 of DP beta chain did not bind to soluble m embrane glycoproteins, nor to lymphoblastoid cells. On the contrary, antibody 208 elicited by fragment 51-61 of DP alpha chain, and antibody 544 against peptide 80-90 of the beta chain, were both able to recognize antigenic determ inants in all glyco protein preparations.
While the lack of reactivity of the first antibody may be ascribed to an internal localization of the peptide F used for immunization, the two latter ap-parently localize two exposed regions in the DP molecule, one corresponding to pos. 51-61 of the alpha chain, the other to pos. 80-90 of the beta chain. This last sequence includes the four-residue fragm ent 84-87 that differs between D P 2 and D P 3 molecules [6] . It is interesting that this regions corre sponds to a stretch of high structural variability in all Class II antigens.
As far as the specificity of those two antibodies is concerned, it is likely that antibody 208 (anti-D) rec ognizes DP as well as D R molecules, because of the high sequence homology in the 51 -61 region of alpha chain of the two proteins. On the contrary, antibody 544 I.D ., that originally cross-reacted with fragm ent P of H L A -D Q 2,3 antigens, appears to be quite specific for peptide R after immunodepletion, and might be able to discriminate DP molecules from D O . Cross-reactivity to D R molecules is unlikely because of low sequence homology.
The specificity of antibody 544 I.D . for a quite restricted group of antigenic sites seems to be con firmed by the comparison of the binding affinity of this antibody for soluble membrane glycoproteins, with these obtained by testing on the same prepara tions. a group of monomorphic anti-Class II mouse monoclonal antibodies. Independently from the M oAb assayed, the reactivity for the five glyco protein preparations decreases in the order: CLL 54, CLL 52, CLL 51, CLL 53, CLL 55.
With oversimplification, the difference in affinity of a monoclonal antibody for the glycoprotein prepa-
